Interferon Inhibitory Activity in Patients With Multiple Sclerosis

Archives of Neurology
doi 10.1001/archneur.63.11.1579
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology
1999English

The Effect of Interferon-Beta on Oxidative Stress in Patients With Multiple Sclerosis

Annals of the College of Medicine, Mosul
2018English

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Australian and New Zealand Journal of Medicine
2000English

Development of Myasthenia Gravis in Two Patients With Multiple Sclerosis Following Interferon Treatment

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2004English

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine
GeneticsPharmacologyMolecular BiologyBiochemistryMedicineToxicologyPharmaceutics
2004English

Intrathecal Interferon for Multiple Sclerosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
1982English

Therapeutic Efficacy of Interferon Β-1b in Japanese Patients With Optic-Spinal Multiple Sclerosis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Mortality in Patients With Multiple Sclerosis

Neurology
Neurology
2013English

Neutralizing Antibodies in Interferon Beta Treated Patients With Multiple Sclerosis: Knowing What to Do Now

Journal of Neurology
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy